BioScrip Acquires CarePoint for $223 Million

Source: PharmaManufacturing.com

Jun 18, 2013

Bloomberg Businessweek

BioScrip Inc. plans to expand its drug infusion business with a new acquisition of CarePoint for $223 million. BioScrip, Inc. provides medication infusion services such as IVs and administers prescription drug benefits. CarePoint Partners provides infustion services at walk-in locations and patients'homes, minizing the need for patients to go to hospitals for treatment. BioScrip expects annual revenue of $160 million from CarePoint. Read the full story.